In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath of UCLA, Kristen Fortney of BioAge Labs, Stanislav Skakun of Biodata, and Peter Fedichev of GERO to discuss biomarkers and their critical role in developing and evaluating drugs and therapies that treat the root causes of aging.
November 30, 2020
Recently on Lifespan.io, we reported the rather overhyped findings of a study that presented hyperbaric oxygen therapy as an effective way to reverse human aging. The Sheekey Science Show offers its own explanation on this study and the reactions of multiple media publications to it.
November 30, 2020
A human study on the popular supplement resveratrol on heart failure patients has been published, and the results are significant. What is resveratrol? Resveratrol, is a naturally occurring stilbenoid, a type of […]
November 27, 2020
The Oxford Society for Ageing and Longevity has recently started hosting online webinars with some of the leading figures in the field. On November 25th, Dr. Aubrey de Grey from SENS Research Foundation gave a […]
November 26, 2020
A new study published in the Journals of Gerontology has shown that the epigenetic clock GrimAge is a strong predictor of the effects of aging, particularly all-cause mortality: the likelihood of dying from […]
November 25, 2020
Recent research published in Nature Biomedical Engineering has shown a way to dramatically improve the feasibility of transplanting therapeutic cells, particularly […]
November 24, 2020
For this week's Lifespan News, Brent Nally discusses the 2020 Century Summit, the effects of aged blood on gene expression, lung organoids and COVID-19, OneSkin's senotherapeutic skin cream, a new book on AI and longevity, and cell virtualization for fighting cancer.